SMS Pharmaceuticals Limited — Others, 14-08-2025: Monitoring Agency Report

SMS Pharmaceuticals has released its monitoring agency report for the quarter ended June 30, 2025, concerning its Rs. 114.30 Cr private placement of convertible share warrants. The report confirms there is no deviation from the stated objects of the issue. Funds allocated for Capital Expenditure have been fully utilized. A significant portion of the unutilised funds, specifically Rs. 38.10 Cr, has been temporarily deployed towards working capital requirements, including loan repayments. Funds designated for General Corporate Purposes are yet to be utilized. This report indicates transparent utilization of raised capital for company growth and operational needs.